Page last updated: 2024-08-23

tobramycin and Cancer of Cervix

tobramycin has been researched along with Cancer of Cervix in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, H; He, J; Li, X; Lu, T; Qin, L; Tang, L; Wu, S; Xie, J; Xu, W	1

Other Studies

1 other study(ies) available for tobramycin and Cancer of Cervix

Article	Year
Tobramycin suppresses HUWE1 degradation to control MCL-1 stability during tumour development. Clinical and experimental pharmacology & physiology, 2020, Volume: 47, Issue:9 Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Caco-2 Cells; Cell Proliferation; Drug Repositioning; Enzyme Inhibitors; Female; G2 Phase Cell Cycle Checkpoints; HEK293 Cells; HeLa Cells; Hep G2 Cells; Histones; Humans; Molecular Docking Simulation; Myeloid Cell Leukemia Sequence 1 Protein; Protein Stability; Proteolysis; Tobramycin; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Ubiquitination; Uterine Cervical Neoplasms	2020

Article

Year

Tobramycin suppresses HUWE1 degradation to control MCL-1 stability during tumour development.

Clinical and experimental pharmacology & physiology, 2020, Volume: 47, Issue:9

Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Caco-2 Cells; Cell Proliferation; Drug Repositioning; Enzyme Inhibitors; Female; G2 Phase Cell Cycle Checkpoints; HEK293 Cells; HeLa Cells; Hep G2 Cells; Histones; Humans; Molecular Docking Simulation; Myeloid Cell Leukemia Sequence 1 Protein; Protein Stability; Proteolysis; Tobramycin; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Ubiquitination; Uterine Cervical Neoplasms

2020